Central muscarinic antinociception induced by ET-142 and SS-20 in rodents

Drug Development Research

Volumn 42, Issue 1, 1997, Pages 26-34

  Ghelardini, Carla ^a,b   Galeotti, Nicoletta ^a   Fantetti, Lia ^a   Gualtieri, Fulvio ^a   Dei, Silvia ^a   Scapecchi, Serena ^a   Bartolini, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Department of Pharmacology ^*  (Italy)

Author keywords

Analgesia; Antinociception; Cholinergic system

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; ANTINOCICEPTIVE AGENT; ATROPINE; ATROPINE METHYL BROMIDE; DICYCLOVERINE; ET 142; HEMICHOLINIUM 3; NALOXONE; PIRENZEPINE; SS 20; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CHOLINERGIC TRANSMISSION; GUINEA PIG; HOT PLATE TEST; ILEUM CONTRACTION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031423399     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199709)42:1<26::AID-DDR2>3.0.CO;2-T     Document Type: Article

References (23)

1. Bartolini A, Galli A, Ghelardini C, Giotti A, Malcangio M, Malmberg-Aiello P, Zucchi PL (1987): Antinociception induced by systemic administration of local anaesthetics depends on a cholinergic mechanism. Br J Pharmacol 92:711-721.
2. Bartolini A, Ghelardini C, Fantetti L, Malcangio M, Malmberg-Aiello P, Giotti A (1992): Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol 105:77-82.
3. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM (1961): A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
4. George R, Haslett WL, Jendel DJ (1962): The central action of a metabolite of tremorine. Life Sci 1:361-363.
5. Ghelardini C, Malmberg-Aiello P, Giotti A, Malcangio M, Bartolini A (1990): Investigation into atropine-induced antinociception. Br J Pharmacol 101:49-54.
6. Ghelardini C, Giotti A, Gualtieri F, Matucci R, Romanelli MN, Scapecchi S, Teodori E, Bartolini A (1992): Presynaptic auto-and hetero-receptors in the cholinergic regulation of pain. In Angeli P, Gulini U, Quaglia W (eds): Trends in Receptor Research. Amsterdam: Elsevier Science Publishers, pp 95-114.
7. Ghelardini C, Gualtieri F, Romanelli MN, Angeli P, Pepeu G, Giovannini MG, Casamenti F, Malmberg-Aiello P, Giotti A, Bartolini A (1997): Stereoselective increase in cholinergic transmission by R-(+)-hyoscyamine. Neuropharmacology 36:281-294.
8. Gualtieri F, Bottalico C, Calandrella A, Dei S, Giovannoni P, Mealli S, Romanelli MN, Scapecchi S, Teodori E, Galeotti N, Ghelardini C, Bartolini A, Giotti A (1994): Presynaptic cholinergic modulators as potent nootropic and analgesic drugs. II. 2-phenoxy, 2-phenylthio and 2-phenylamino alkanoic acid esters. J Med Chem 37:1712-1719.
9. Haley TJ, McCormick WG (1957): Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12:12-15.
10. Harris LS, Dewey WL, Howes J, Kennedy JS, Pars H (1969): Narcotic antagonist analgesics: Interaction with cholinergic systems. J Pharmacol Exp Ther 169:17-22.
11. Hendershot LC, Forsaith J (1959): Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics. J Pharmacol Exp Ther 125:237-240.
12. Herz A (1962): Wirkungen des Arecolins auf das Zentralnervensystem. Arch Exp Pathol Pharmakol 242:414-429.
13. Ireson C (1970): A comparison of the antinociceptive action of cholinomimetic and morphine-like drugs. Br J Pharmacol 40:92-101.
14. Irwin S (1966): Comprehensive observational assessment. Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of mouse. Psychopharmacology 13:222-257.
15. Koster R, Anderson M, De Beer EJ (1959): Acetic acid for analgesic screening. Fed Proc 18:412.
16. Kuribara H, Higuchi Y, Takadoro S (1977): Effects of central depressants on rota-rod and traction performances in mice. Jpn J Pharmacol 27:117-126.
17. Leighton GE, Rodriguez RE, Hill RG, Hughes J (1988): k-opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br J Pharmacol 93:553-560.
18. Lenke D (1958): Narkosepotenzierende und analgestische Wirkung von 1,4-dipyrrolidino-2-butin. Arch Exp Pathol Pharmacol 234:35-45.
19. Lentz TL, Liley L, Michaelson U (1969): Some actions of anticholinergic drugs. Br J Pharmacol 32:156-162.
20. B antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen. Br J Pharmacol 103:1303-1308.
21. O'Callaghan JP, Holtzman SG (1975): Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J Pharmacol Exp Ther 192:497-505.
22. Paton WDM, Vizi ES (1969): The inhibitory action of noradrenaline and acetylcholine output by guinea-pig longitudinal muscle strip. Br J Pharmacol 35:10-28.
23. Pedigo NW, Dewey WL, Harris LS (1975): Determination and characterization of the antinociceptive activity of intracerebroventricularly administered acetylcholine. J Pharmacol Exp Ther 193:845-852.